{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:14:31Z","timestamp":1790997271978,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.niox.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T07:04:48Z","timestamp":1681196688000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism"],"prefix":"10.1016","volume":"134-135","author":[{"given":"Lorena","family":"de Jager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Borecki","family":"Vidigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blenda Hyedra","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Souza","family":"Reginato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Maria","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Matias","family":"Higashi-Mckeown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Marques","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Soares","family":"Rasquel de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldiceu Aparecido","family":"Verri Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela Scalianti","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos C\u00e9sar","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phileno","family":"Pinge-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-1530","authenticated-orcid":false,"given":"Marli Cardoso","family":"Martins-Pinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson \u2019 s disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.niox.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2008.04.015","article-title":"The 6-hydroxydopamine model: news from the past","volume":"14","author":"Blandini","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.niox.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.niox.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.niox.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.niox.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.niox.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s007020050171","article-title":"Parkinson's disease: a major hypokinetic basal ganglia disorder","volume":"106","author":"Sian","year":"1999","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.niox.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.niox.2023.04.003_bib9","first-page":"25","article-title":"Disautonomia na Doen\u00e7a de Parkinson, Revis\u00e3o da literatura","volume":"47","author":"Nicaretta","year":"2011","journal-title":"Rev. Bras. Neurol."},{"key":"10.1016\/j.niox.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S1353-8020(13)70030-0","article-title":"Exercise: is it a neuroprotective and if so, how does it work?","volume":"20","author":"Zigmond","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.niox.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.00406.2014","article-title":"Dysautonomias in Parkinson's disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra","volume":"308","author":"Ariza","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2015.09.024","article-title":"Chemoreflex and baroreflex alterations in Parkinsonism induced by 6-OHDA in unanesthetized rats","volume":"607","author":"Ariza","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.niox.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainres.2016.12.008","article-title":"Cardiovascular dysfunction associated with neurodegeneration in an experimental model of Parkinson's disease","volume":"1657","author":"Falquetto","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.niox.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1179\/135100001101536436","article-title":"Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat","volume":"6","author":"Barthwal","year":"2001","journal-title":"Redox Rep."},{"key":"10.1016\/j.niox.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-002-1009-2","article-title":"Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice","volume":"161","author":"a Del Bel","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.niox.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002512-199812040-00001","article-title":"The role of nitric oxide in neurodegeneration: potential for pharmacological intervention","volume":"12","author":"Molina","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.niox.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neuropharm.2012.07.031","article-title":"7-Nitroindazole down-regulates dopamine\/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease","volume":"63","author":"Yuste","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0891-5849(02)01298-4","article-title":"Characterization and function of mitochondrial nitric-oxide synthase","volume":"34","author":"Giulivi","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib19","first-page":"1","article-title":"NO synthase: structures and mechanisms, nitric oxide -","volume":"23","author":"Daff","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.niox.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuint.2014.04.014","article-title":"The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice","volume":"72","author":"Aras","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.niox.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1046\/j.1471-4159.1996.67062443.x","article-title":"Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase","volume":"67","author":"Di Monte","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.niox.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00441-004-0954-y","article-title":"Neuronal pathology in Parkinson's disease","volume":"318","author":"Schulz","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.niox.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2010.12.026","article-title":"Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease","volume":"50","author":"Broom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuint.2013.09.021","article-title":"Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","volume":"63","author":"Lorenc-Koci","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.niox.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson's disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.898797","article-title":"Nitric oxide involvement in cardiovascular dysfunctions of Parkinson disease","volume":"13","author":"Martins-pinge","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.003_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","article-title":"Neural and immune mechanisms in the of Parkinson's disease","volume":"8","author":"Blandini","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.niox.2023.04.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2018.05.017","article-title":"Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise","volume":"204","author":"de Jager","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.niox.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric oxide and endothelial dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.niox.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.biopha.2017.06.036","article-title":"Inducible nitric oxide synthase: good or bad?","volume":"93","author":"Lind","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.niox.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0463.2011.02737.x","article-title":"KIT amplification and gene mutations in acral\/mucosal melanoma in Korea","volume":"119","author":"Yun","year":"2011","journal-title":"Apmis"},{"key":"10.1016\/j.niox.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.003_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/2277-9175.161223","article-title":"The effect of an specific inducible NO synthase inhibitor, S-methylisothiourea hemisulfate on cisplatin-induced nephrotoxicity; gender-related differences","volume":"4","author":"Ghayyoomi","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.niox.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4522(01)00562-0","article-title":"Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration","volume":"110","author":"Iravani","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exger.2017.07.016","article-title":"Cardiovascular risk and the effect of nitric oxide synthase inhibition in female rats: the role of estrogen","volume":"97","author":"Castardo-De-Paula","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.niox.2023.04.003_bib37","series-title":"The Rat Brain: in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.niox.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s11064-010-0222-3","article-title":"Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease","volume":"35","author":"Ariza","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.niox.2023.04.003_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01020","article-title":"Effects of inducible nitric oxide synthase inhibition on cardiovascular risk of adult endotoxemic female rats: role of estrogen","volume":"9","author":"Castardo-De-Paula","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.niox.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.exger.2012.11.009","article-title":"Aerobic physical training has little effect on cardiovascular autonomic control in aging rats subjected to early menopause","volume":"48","author":"V Tezini","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.niox.2023.04.003_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/44.3.679","article-title":"Semiautomated measurement of nitrate in biological fluids","volume":"44","author":"Navarro-Gonz\u00e1lvez","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.niox.2023.04.003_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2015.01.032","article-title":"Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA","volume":"127","author":"Silva","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.niox.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apha.13264","article-title":"Glutamate and GABA neurotransmission are increased in paraventricular nucleus of hypothalamus in rats induced to 6-OHDA parkinsonism: involvement of nNOS","volume":"226","author":"Turossi Amorim","year":"2019","journal-title":"Acta Physiol."},{"key":"10.1016\/j.niox.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.niox.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0102-76382009000200018","article-title":"Basic notions of heart rate variability and its clinical applicability","volume":"24","author":"Vanderlei","year":"2009","journal-title":"Rev. Bras. Cir. Cardiovasc."},{"key":"10.1016\/j.niox.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11906-012-0290-7","article-title":"Blood pressure variability, cardiovascular risk, and risk for renal disease progression","volume":"14","author":"Parati","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.niox.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00702-003-0016-8","article-title":"Heart rate variability and Parkinson's disease severity","volume":"110","author":"Devos","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.niox.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01928-5","article-title":"Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies","volume":"20","author":"Oka","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.niox.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2016.09.027","article-title":"Heart rate variability in patients with essential tremor: a cross sectional study","volume":"33","author":"Salsone","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.niox.2023.04.003_bib51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00702-015-1393-5","article-title":"Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype","volume":"122","author":"Solla","year":"2015","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.niox.2023.04.003_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jns.2016.09.036","article-title":"Cardiovascular dysfunction in untreated Parkinson's disease: a multi-modality assessment","volume":"370","author":"Strano","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.niox.2023.04.003_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autneu.2013.08.067","article-title":"Reduced sympathetic activity in idiopathic rapid-eye-movement sleep behavior disorder and Parkinson's disease","volume":"179","author":"Sorensen","year":"2013","journal-title":"Auton. Neurosci. Basic Clin."},{"key":"10.1016\/j.niox.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3949\/ccjm.74.Suppl_1.S91","article-title":"Cardiac denervation in patients with Parkinson disease","volume":"74","author":"Goldstein","year":"2007","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118259","article-title":"Cardiovascular evaluation of female rats with 6-OHDA-induced parkinsonism: possible protection by ovarian hormones and participation of nitric oxide","volume":"259","author":"de Campos","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.niox.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1476-5381.1995.tb13256.x","article-title":"Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity","volume":"114","author":"Southan","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.003_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1440-1681.2007.04553.x","article-title":"Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats","volume":"34","author":"Su","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.niox.2023.04.003_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1152\/advan.00114.2010","article-title":"Neural control of the circulation","volume":"35","author":"Thomas","year":"2011","journal-title":"Am. J. Physiol. - Adv. Physiol. Educ."},{"key":"10.1016\/j.niox.2023.04.003_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"V\u00edte\u010dek","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.niox.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1590\/S0482-50042012000500011","article-title":"Inibi\u00e7\u00e3o seletiva da ciclo-oxigenase-2: riscos e benef\u00edcios","volume":"52","author":"Mendes","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.niox.2023.04.003_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.21636","article-title":"Inducible nitric oxide synthase inhibitors: a comprehensive update","volume":"40","author":"Minhas","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.niox.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","article-title":"Oxidative and nitrative protein modifications in Parkinson's disease","volume":"44","author":"Danielson","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tips.2015.10.002","article-title":"Protein S-nitrosylation as a therapeutic target for neurodegenerative diseases","volume":"37","author":"Nakamura","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.niox.2023.04.003_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0107734","article-title":"Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia","volume":"9","author":"Dayal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0008-6363(99)00316-8","article-title":"Inducible nitric oxide synthase and cardiovascular disease","volume":"45","author":"Shah","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2023.04.003_bib66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/S0066-782X2000000400009","article-title":"Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseases","volume":"74","author":"Viaro","year":"2000","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.niox.2023.04.003_bib67","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.0000172626.00296.ba","article-title":"Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction","volume":"25","author":"Gunnett","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2023.04.003_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2023.04.003_bib69","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1152\/ajpheart.00415.2002","article-title":"Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery","volume":"283","author":"Eguchi","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2023.04.003_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.niox.2006.07.003","article-title":"Nitric oxide synthase regulation and diversity: implications in Parkinson's disease","volume":"15","author":"Kavya","year":"2006","journal-title":"Nitric Oxide - Biol. Chem."},{"key":"10.1016\/j.niox.2023.04.003_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vph.2008.06.008","article-title":"Endothelial nitric oxide (NO) and its pathophysiologic regulation","volume":"49","author":"Chatterjee","year":"2008","journal-title":"Vasc. Pharmacol."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860323000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860323000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:30:37Z","timestamp":1736422237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860323000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":70,"alternative-id":["S1089860323000356"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2023.04.003","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}